Combination therapy with pioglitazone plus metformin or sulfonylurea in patients with Type 2 diabetes: Influence of prior antidiabetic drug regimen

Journal of Diabetes and its Complications

Volumn 17, Issue 4, 2003, Pages 211-217

  Rendell, Marc S ^a   Glazer, N Bradly ^b   Ye, Zhan ^b  

^a Creighton Diabetes Center   (United States)

^b TAKEDA PHARMACEUTICALS   (United States)

Author keywords

Glycemic control; Lipids; Metformin; Pioglitazone; Sulfonylurea

Indexed keywords

ANTIDIABETIC AGENT; GLIBENCLAMIDE; GLIPIZIDE; HEMOGLOBIN A1C; METFORMIN; PIOGLITAZONE; SULFONYLUREA;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HUMAN; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0142029431     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-8727(03)00005-9     Document Type: Review

References (9)

1. ACTOS [package insert] (2002). Lincolnshire, IL: Takeda Pharmaceuticals North America.
2. Tests of glycemia in diabetes. Diabetes Care. 25(Suppl. 1):2002;S97-S99.
3. Chow C.C., Tsang L.W., Sorensen J.P., Cockram C.S. Comparison of insulin with or without continuation of oral hypoglycemic agents in the treatment of secondary failure in NIDDM patients. Diabetes Care. 18:1995;307-314.
4. Einhorn D., Rendell M., Rosenzweig J., Egan J.W., Mathisen A.L., Schneider R.L. Pioglitazone hydrochloride in combination with metformin in the treatment of type 2 diabetes mellitus: A randomized, placebo-controlled study. Clinical Therapeutics. 22:2000;1395-1409.
5. Fonseca V., Rosenstock J., Patwardhan R., Salzman A. Effect of metformin and rosiglitazone combination therapy in patients with type 2 diabetes mellitus: A randomized controlled trial. JAMA. 283:2000;1695-1702.
6. Inzucchi S.E., Maggs D.G., Spollett G.R., Page S.L., Rife F.S., Walton V., Shulman G.I. Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus. New England Journal of Medicine. 338:1998;867-872.
7. Kipnes M.S., Krosnick A., Rendell M.S., Egan J.W., Mathisen A.L., Schneider R.L. Pioglitazone hydrochloride in combination with sulfonylurea therapy improves glycemic control in patients with type 2 diabetes mellitus: A randomized, placebo-controlled study. American Journal of Medicine. 111:2001;10-17.
8. Sugiyama Y., Shimura Y., Ikeda H. Effects of pioglitazone on hepatic and peripheral insulin resistance in wistar fatty rats. Arzneimittelforschung. 40:1990;436-440.
9. Turner R.C., Cull C.A., Frighi V., Holman R.R. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: Progressive requirement for multiple therapies (UKPDS 49). JAMA. 281:1999;2005-2012.